Manufacturer of Mobility and Postural Seating Solutions for Healthcare, Educational and Recreational Special Needs
An opportunity has arisen to acquire an award-winning provider of mobility and seating solutions for individuals with needs ranging from mild mobility challenges to more complex physical or cognitive requirements.
The company manufactures, assembles, and distributes a range of specialist mobility equipment, seating systems, and associated products for children, teenagers, and adults.
Supporting users’ fitness, wellbeing, and social inclusion, the company’s offering is widely regarded as a gold standard in the market, recognised for its modern design, innovation, build quality, and strong customer support. The business also benefits from a robust intellectual property portfolio, including several patents and trademarks.
The company designs and manufactures its products from a dedicated UK-based facility. Its own-brand extensive product range provides practical, life-enhancing solutions, with a modular approach that allows each product to be tailored to individual needs, when required.
Over 50% of revenue is generated through regular sales to schools and commercial distributors of healthcare equipment, with the remainder being direct sales to end-users and their families.
The business continues to invest in innovation, regularly introducing new products to meet evolving customer needs. With limited direct competition, the company is considered a market leader, supported by its strong product range, high manufacturing standards, and compliance with UK and international regulations.
Highlights
- Award-winning, innovative engineering and manufacturing company.
- 25+ years of trading history with strong reputation
- Well-established, global distributor and dealer base.
- Strong brand and IP portfolio with patented products and technologies.
- Further product development in the pipeline.
Financial Overview
| F/Y: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Sales revenue | £1,573,144 | £1,648,648 | £1,760,605 | £2,094,420 | £1,762,354 |
| Gross profit | £508,027 | £465,373 | £509,013 | £524,330 | £760,215 |
| Percentage | 32% | 28% | 29% | 25% | 43% |
| Adjusted EBITDA | £120,068 | £113,014 | £82,720 | £78,764 | £88,511 |
| Percentage | 8% | 7% | 5% | 4% | 5% |
- Directors’ replacement cost is accounted for within the Adjusted EBITDA.
- Retirement sale
Offers Invited